Status:
COMPLETED
A New Biomarker for the Non-invasive Diagnosis of Rejection After Heart Transplantation
Lead Sponsor:
Vastra Gotaland Region
Collaborating Sponsors:
Lund University Hospital
Karolinska University Hospital
Conditions:
Heart Transplant Rejection
Eligibility:
All Genders
Brief Summary
This study is a prospective, observational multi-center cohort study. The study will consist of patients undergoing heart transplantation. The main purpose is to test a new biomarker for rejection aga...
Detailed Description
The primary objective is a comparison of an the established, invasive diagnostic test, the endomyocardial biopsy (EMB) against a new, non-invasive test. The new test is the measurement of donor-derive...
Eligibility Criteria
Inclusion
- Patient on waiting list for heart transplantation
- Signed informed consent
Exclusion
- 1\. Follow-up outside Sweden
Key Trial Info
Start Date :
March 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT03477383
Start Date
March 1 2016
End Date
December 31 2021
Last Update
May 2 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Transplantation Center, Sahlgrenska University Hospital
Gothenburg, Sweden, 41234
2
Pediatric Heart Center, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital
Gothenburg, Sweden, 41685
3
Pediatric Heart Center, Skåne University Hospital
Lund, Sweden, 22241
4
Pediatric Heart Center, Karolinska University Hospital
Stockholm, Sweden, 17176